DISEASE INDICATIONS: Rheumatoid Arthritis
MANUFACTURER: Galapagos
USAGE: Oral
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Pharmaceuticals and Medical Devices Agency (PMDA)
Jyseleca is a pharmaceutical medication that contains the active ingredient filgotinib. It belongs to a class of medications known as Janus kinase (JAK) inhibitors and is primarily used in the treatment of various autoimmune diseases, including rheumatoid arthritis. Filgotinib works by targeting specific enzymes involved in the inflammatory process, helping to reduce inflammation and manage the symptoms of these conditions.
